The company’s technology, created by scientists from institutions such as MIT, Harvard and Stanford, uses artificial intelligence to match patients with providers who can deliver the most effective treatments. The goal of the system is not only to enable precision treatments for patients, but also, in doing so, to lower overall healthcare costs by reducing the need for readmissions and other avoidable post-operative care.
Health[at]Scale’s clients include hospital systems, insurers and self-insured employers, though they declined to name any specific users to TechCrunch. Optum’s funding will go toward increased sales and marketing to recruit more clients.
More articles about AI:
IBM’s AI distinguishes between healthy, cancerous cells in breast tumors
UPenn Medicine’s AI tool for data analytics is open-source, free to the public
AI hearing aid uses brain activity to amplify specific voices
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.